E-LIB Suche - Ergebnisse für: Samineni, Divya

1

Clinical pharmacology strategies to accelerate the developm..:

Liao, Michael Z. ; Lu, Dan ; Lu, Tong...
Advanced Drug Delivery Reviews. 207 (2024) - p. 115193 , 2024

Link: https://doi.org/10.1016/..

2

Dose Optimization in Oncology Drug Development: An Internat..:

Samineni, Divya ; Venkatakrishnan, Karthik ; Othman, Ahmed A....
Clinical Pharmacology & Therapeutics. , 2024

Link: https://doi.org/10.1002/..

3

Fire Detection Through Surveillance Videos Using Deep Learn..:

, In: Lecture Notes in Networks and Systems; Proceedings of 3rd International Conference on Recent Trends in Machine Learning, IoT, Smart Cities and Applications,

Sai Padmakar, Kasindula ; Sathvik Chowdary, Samineni ; Kumar Jaswanth, Pavuluri.. - p. 345-353 , 2023

Link: https://doi.org/10.1007/..

4

Anti-CD79B Antibody–Drug Conjugate DCDS0780A in Patients wi..:

Herrera, Alex F. ; Patel, Manish R. ; Burke, John M....
Clinical Cancer Research. 28 (2022) 7 - p. 1294-1301 , 2022

Link: https://doi.org/10.1158/..

5

Bioavailability Evaluation of Venetoclax Lower-Strength Tab..:

Badawi, Mohamed ; Chen, Xin ; Marroum, Patrick...
Clinical Drug Investigation. 42 (2022) 8 - p. 657-668 , 2022

Link: https://doi.org/10.1007/..

6

Pharmacokinetics and Exposure-Response Analysis of Venetocl..:

Samineni, Divya ; Gibiansky, Leonid ; Wang, Bei...
Advances in Therapy. 39 (2022) 8 - p. 3635-3653 , 2022

Link: https://doi.org/10.1007/..

7

Anti-CD79B Antibody–Drug Conjugate DCDS0780A in Patients wi..:

Herrera, Alex F ; Patel, Manish R ; Burke, John M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365381/. , 2022

Link: http://www.ncbi.nlm.nih...

8

Bioavailability Evaluation of Venetoclax Lower-Strength Tab..:

Badawi, Mohamed ; Chen, Xin ; Marroum, Patrick...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338003/. , 2022

Link: http://www.ncbi.nlm.nih...

9

Pharmacokinetics and Exposure-Response Analysis of Venetocl..:

Samineni, Divya ; Gibiansky, Leonid ; Wang, Bei...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309146/. , 2022

Link: http://www.ncbi.nlm.nih...

10

Model‐Informed Therapeutic Dose Optimization Strategies for..:

Liao, Michael Z. ; Lu, Dan ; Kågedal, Matts...
Clinical Pharmacology & Therapeutics. 110 (2021) 5 - p. 1216-1230 , 2021

Link: https://doi.org/10.1002/..

11

A Phase I dose‐escalation study of DCLL9718S, an antibody‐d..:

Daver, Naval ; Salhotra, Amandeep ; Brandwein, Joseph M....
American Journal of Hematology. 96 (2021) 5 - p. , 2021

Link: https://doi.org/10.1002/..

12

Population Pharmacokinetics and Exposure–Response Analyses ..:

Samineni, Divya ; Huang, Weize ; Gibiansky, Leonid...
Advances in Therapy. 39 (2021) 1 - p. 598-618 , 2021

Link: https://doi.org/10.1007/..

13

Population Pharmacokinetics and Exposure–Response Analyses ..:

Samineni, Divya ; Huang, Weize ; Gibiansky, Leonid...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799559/. , 2021

Link: http://www.ncbi.nlm.nih...

14

A Phase I dose‐escalation study of DCLL9718S, an antibody‐d..:

Daver, Naval ; Salhotra, Amandeep ; Brandwein, Joseph M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252033/. , 2021

Link: http://www.ncbi.nlm.nih...

15

A phase 2 study of venetoclax plus R-CHOP as first-line tre..:

Morschhauser, Franck ; Feugier, Pierre ; Flinn, Ian W...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869186/. , 2021

Link: http://www.ncbi.nlm.nih...